Awful way businesswoman, 40, died after plastic surgery on her BUTTOCKS
Natália Cavanellas, 40, went into cardiac arrest Monday afternoon just moments after she had received an injection in her buttocks while on the operating table at San Gennaro Hospital in Sao Paulo.
A Sao Paulo Civil Police report obtained by G1 news outlet showed that Cavanellas contracted the services of renown plastic surgeon Edgar Lopez to undergo a liposuction, injection to the buttocks and additional work on her breast implants.
Lopez was nearing the end of the cosmetic surgery at about 4:20 pm local time when he applied an injection to the gluteal area.
Cavanellas' heart stopped beating and the medical staff attempted to revive her before she was confirmed dead.
'The medical team reportedly began resuscitation maneuvers, but were ultimately unsuccessful, although the victim responded to initial resuscitation,' the police report said.
'The patient died in the operating room itself.'
The operating staff told the investigating officers that they believed that Cavanellas' cardiac arrest may have been caused by a 'fat embolism,' which is caused by fat particles that reach the bloodstream and block the flow of blood.
Cavanellas was not suffering from any known illnesses at the time of the surgery, her sister told the police.
The businesswoman had gotten breast implants around two years ago and did not report any issues.
A lawyer for Lopez said in a statement that Cavanellas had undergone a series of tests prior to the procedures.
'Unfortunately, the patient developed a serious complication, compatible with pulmonary embolism, a rare event, but recognized in the medical literature as possible, even with all the preventive measures adopted,' the attorney said.
'The responsible professional has been providing full assistance to the family, remaining available for technical clarifications, always respecting the patient, the family and medical confidentiality.'
Lopez claimed on his professional website to be an expert in high-definition liposuction, which is also known as liposculpture, and mammoplasty.
The surgeon also boasted about having been the first doctor in the South American nation to have used Renuvion, a minimal invasive technology that tightens the skin whether a person undergoes liposuction or not.
While Lopez is a member of the American Society for Aesthetic Plastic Surgery and the International Society for Aesthetic Plastic Surgery, the Brazilian Society of Plastic Surgery stripped his recognition in May 2021 after it was found that he was not following their guidelines.
In July 2021, the Regional Medical Council of the State of São Paulo banned Lopez from practicing medicine for six months before a court intervened two months later and reduced the punished to four months.
The ban was extended in November and Lopez was allowed to resume his duties in May 2022.
Cavanellas leaves behind her husband, whom she married in 2019, and the couple's three-year-old daughter.
She ran her own public relations, marketing and events planning company, offering her support to a 'community with more than 800 businesswomen and executives.'
In March, Cavanellas was honored by the São Paulo City Council as one of the 100 most successful women in business.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 hours ago
- The Sun
Hulk Hogan's official cause of death reveals secret cancer battle after wrestling icon died at 71 from heart attack
HULK Hogan's cause of death has been released. The 71-year-old WWE star was rushed to the hospital on July 24 after suffering a cardiac arrest in his South Florida home. 2 2 He died from an acute myocardial infarction, which is commonly known as a heart attack, according to records from the Pinellas County Forensic Science Center obtained by The U.S. Sun. An examination of the wrestling star found that he had a history of atrial fibrillation, which is a heart rhythm disorder that can lead to an irregular or rapid heart rate. He also had a history of leukemia CLL, which is a type of cancer that affects white blood cells, the documents state. Hogan never told the public about his battle with cancer. A spokesperson for the center said the family plans to cremate the body, according to Page Six. Hogan had been dealing with significant health issues for months before he went into cardiac arrest at his $11.5 million mansion in Clearwater. He had a neck surgery in May, and was rushed to the hospital afterwards over complications with his recovery. In June, he suffered a series of health issues that left him reportedly unable to feel his legs or walk with a cane. However, multiple people, including his wife Sky, downplayed his issues and insisted that he was making great progress. .
Reuters
2 days ago
- Reuters
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
July 29 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead (ARWR.O), opens new tab and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche (ROG.S), opens new tab had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March.
Reuters
3 days ago
- Reuters
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
July 28 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab said on Monday it will resume shipping of its gene therapy Elevidys to patients with a rare muscular disorder who can walk, after the FDA recommended the removal of a voluntary hold that was placed on the therapy. However, the use of the gene therapy remains on hold for Duchenne Muscular Dystrophy patients who cannot walk, the FDA said, adding that it is continuing to work with the company while investigating the death of two patients. The FDA's recommendation for ambulatory patients - those who can walk - followed a probe that showed the death of an eight-year-old boy in Brazil, was unrelated to the gene therapy, the agency said. Roche, which has partnered with Sarepta for commercialization outside the U.S., had previously said the patient's death was not related to the therapy, according to the reporting physician's assessment. Sarepta is also facing intense scrutiny following the death of two non-ambulatory teenage boys associated with Elevidys, as well as a 51-year-old man who had received its experimental gene therapy SRP-9004.
